As we suspected last month, KV's poor ethical choices led to it's investigation by several federal authorities, including the FDA and SEC. News today is that KV has layed off about 1000 employees . See prior blogs to see the story unfold from product recalls, to misbranded products, to family feuds, to potential board of directors liability for selling products which they may have known were not made to the drug specifications approved by the FDA.
No comments:
Post a Comment